Simian immunodeficiency virus Nef gene regulates the production of 2-LTR circles in vivo

Virology

Volumn 306, Issue 1, 2003, Pages 100-108

  Clarke, S ^a   Almond, N ^a   Berry, N ^a  

^a NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

Author keywords

2 LTR circles; Attenuation; Lymphoid tissue; Nef; Simian immunodeficiency virus; Viral load

Indexed keywords

CIRCULAR DNA; GAG PROTEIN; NEF PROTEIN; VIRUS DNA; VIRUS RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATTENUATION; BLOOD ANALYSIS; BLOOD LEVEL; CLONE; CONTROLLED STUDY; EPISOME; GENE DISRUPTION; GENE FUNCTION; GENETIC ANALYSIS; IN VIVO STUDY; LONG TERMINAL REPEAT; LYMPHOID TISSUE; MOLECULAR CLONING; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROVIRUS; QUANTITATIVE GENETICS; SIMIAN IMMUNODEFICIENCY VIRUS; TECHNIQUE; TISSUE LEVEL; VIRAL GENETICS; VIREMIA; VIRUS DETECTION; VIRUS GENE; VIRUS INFECTION; VIRUS REPLICATION; WILD TYPE;

ANIMALS; DNA, VIRAL; GENE EXPRESSION REGULATION, VIRAL; GENE PRODUCTS, GAG; GENES, NEF; LYMPHOID TISSUE; MACACA FASCICULARIS; RNA, VIRAL; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; TERMINAL REPEAT SEQUENCES; VIREMIA; VIRUS REPLICATION;

SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 0037293113     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0042-6822(02)00043-0     Document Type: Article

References (41)

1. Almond N., Kent K., Cranage M., Rud E., Clarke B., Stott E.J. Protection by attenuated simian immunodeficiency virus in macaques against challenge with virus-infected cells. Lancet. 345:1995;1342-1344.
2. Bell I., Ashman C., Maunghan J., Hooker E., Cook F., Reinhart T.A. Association of simian immunodeficiency virus Nef with the T-cell receptor (TCR) 86 chain leads to TCR down-modulation. J. Gen. Virol. 79:1998;2717-2727.
3. Berry N., Ariyoshi K., Jaffar S., Sabally S., Corrah T., Tedder R., Whittle H. Low peripheral blood viral HIV-2 RNA in individuals with high CD4 percentage differentiates HIV-2 from HIV-1 infection. J. Hum. Virol. 1:1998;457-469.
4. Bukrinsky M., Sharova N., Stevenson M. Human immunodeficiency virus type 1 2-LTR circles reside in a nucleoprotein complex which is different from the pre-integration complex. J. Virol. 67:1993;6863-6865.
5. Bukrinsky M.J., Sharova N., Dempsey M.P., Stanwick T.L., Bukrinskaya A.G., Haggerty S., Stevenson M. Active nuclear import of human immunodeficiency virus type 1 preintegration complexes. Proc. Natl. Acad. Sci. USA. 89:1992;6580-6584.
6. Butler S.L., Johnson E.P., Bushman F.D. Human immunodeficiency virus cDNA metabolism notable stability of two-long terminal repeat circles. J. Virol. 76:2002;3739-3747.
7. Canto-Nogues C., Jones S., Sangster R., Silvera P., Hull R., Cook R., Hall G., Walker B., Stott E.J., Hockley D., Almond N. In situ hybridisation and immunolabelling study of the early replication of simian immunodeficiency virus (SIVmacJ5) in vivo. J. Gen. Virol. 82:2001;2225-2234.
8. Cao Y., Qin L., Zhang L., Safrit J., Ho D. Virologic and immunologic characterisation of long-term survivors of human immunodeficiency virus type 1 infection. N. Engl. J. Med. 332:1995;201-208.
9. Cara A., Vargas J., Keller M., Jones S., Mosoian A., Gurtman A., Cohen A., Parkas V., Wallach F., Chusid E., Gelman H., Klotman M.E. Circular viral DNA and anomalous junction sequence in PBMC of HIV-infected individuals with no detectable plasma HIV RNA. Virology. 292:2002;1-5.
10. Carl S., Iafrate A.J., Skowronski J., Stahl-Hennig C., Kirchoff F. Effect of the attenuating deletion and of sequence alterations evolving in vivo on simian immunodeficiency virus C8-nef function. J. Virol. 73:1999;2790-2797.
11. Chun T.-W., Finzi D., Margolick J., Chadwick K., Schwartz D., Siliciano R.F. In vivo fate of HIV-1-infected T cells quantitative, analysis of the transition to stable latency. Nat. Med. 1:1995;1284-1290.
12. Coffin J.M. HIV population dynamics in vivo implications for genetic variation, pathogenesis and therapy. Science. 267:1995;483-489.
13. Farnet C.M., Haseltine W.A. Circularization of HIV-1 DNA in vitro. J. Virol. 65:1991;6942-6952.
14. Gallimore, A. (1995). Ph.D. thesis.
15. Gallimore A., Cranage M., Cook N., Almond N., Bootman J., Rud E., Silvera P., Dennis M., Corcoran T., Stott J., McMichael A., Gotch F. Early suppression of SIV replication by CD8+ nef-specific cytotoxic T cells in vaccinated macaques. Nat. Med. 1:1995;1167-1173.
16. Jurrians S., Goudsmit J. Fluctuations in steady state level of genomic HIV-1 RNA and replication intermediates related to disease progression rate. Immunol. Lett. 51:1996;15-22.
17. Heidecker G., Munoz H., Lloyd P., Hodge D., Ruscetti F.W., Morton W.R., Hu S.-L., Benveniste R.E. Macaques infected with cloned simian immunodeficiency virus show recurring nef gene alterations. Virology. 249:1998;260-274.
18. Lifson J.D., Nowak M.A., Goldstein S., Rossio J.L., Kinter A., Vasquez G., Wiltrout T.A., Brown C., Schneider D., Wahl L., Lloyd A.L., Williams J., Elkins W.R., Fauci A.S., Hirsch V.M. The extent of early viral replication is a critical determinant of the natural history of simian immunodeficiency virus infection. J. Virol. 71:1997;9508-9514.
19. Lindback S., Karlsson A.C., Mittler J., Blaxhult A., Carlsson M., Briheim G., Sonnerborg A., Gaines H. Viral dynamics in primary HIV-1 infection. AIDS. 14:2000;2283-2291.
20. Luciw P.A., Pratt-Lowe E., Shaw K.E., Levy J.A., Cheng-Mayer C. Persistent infection of rhesus macaques with T-cell-line-tropic and macrophage-tropic clones of simian/human immunodeficiency viruses (SHIV). Proc. Natl. Acad. Sci. USA. 92:1995;7490-7494.
21. McCormick-Davis C., Zhao L.J., Makherjee S., Leung D., Joag L.J., Narayan O., Stephens E.B. Chronology of genetic changes in the vpu, env and nef genes of chimaeric simian-human immunodeficiency virus (strain HXB2) during acquisition of virulence for pig-tailed macaques. Virology. 248:1998;275-283.
22. Mellors J.W., Rinaldo C.R., Gupta P., White R.M., Todd J.A., Kingsley L.A. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science. 272:1996;1167-1170.
23. Miller M.D., Warmerdam M.T., Gaston I., Greene W.C., Feinberg M.B. The human immunodeficiency virus-1 nef gene product a positive factor for viral infection and replication in primary lymphocytes and macrophages. J. Exp. Med. 179:1994;101-113.
24. Norley S., Beer B., Binninger-Schinzel D., Cosma C., Kurth R. Protection from pathogenic SIVmac challenge following short-term infection with a nef-deficient attenuated virus. Virology. 219:1996;195-205.
25. Panther L.A., Coombes R.W., Aung S.A., dela Rosa C., Gretch D., Corey L. Unintegrated HIV-1 circular 2-LTR proviral DNA as a marker of recently infected cells relative effect of recombinant CD4, zidovudine and saquinavir in vitro. J. Med. Virol. 58:1999;165-173.
26. Pauza C.D., Trivedi P., McKechnie T.S., Richman D.D., Graziano F.M. 2-LTR circular viral DNA as a marker for human immunodeficiency virus type 1 infection in vivo. Virology. 205:1994;470-478.
27. Pierson T.C., Kieffer T.L., Ruff C.T., Buck C., Gange S.J., Siliciano R.F. Intrinsic stability of episomal circles formed during human immunodeficiency virus type 1 replication. J. Virol. 76:2002;4138-4144.
28. Polacino P.S., Liang H.A., Clark E.A. Formation of simian immunodeficiency virus long terminal repeat circles in resting T-cells requires both T cell receptor and IL-2- dependent activation. J. Exp. Med. 182:1995;617-621.
29. Reimann K.A., Li J.T., Voss G., Lekutis C., Tenner-Racz K., Racz P., Lin W., Montefiori D.C., Lee-Parritz D.E., Lu Y., Collman R.G., Sodroski J., Letvin N.L. An env gene derived from a primary human immunodeficiency virus type 1 isolate confers high in vivo replicative capacity to a chimeric simian/human immunodeficiency virus in rhesus monkeys. J. Virol. 70:1996;3198-3206.
30. Rud E.W., Cranage M., Yon J., et al. Molecular and biological characterisation SIVmac32H proviral clones containing nef size variants. J. Gen. Virol. 75:1994;529-543.
31. Schacker T.W., Hughes J.P., Shea T., Coombs R.W., Corey L. Biological and virologic characteristics of primary HIV infection. Ann. Intern. Med. 128:1998;613-620.
32. Schaeffer E., Geleziunas R., Greene W.C. Human immunodeficiency virus type 1 Nef functions at the level of virus entry by enhancing cytoplasmic delivery of virions. J. Virol. 75:2001;2993-3000.
33. Sharkey M.E., Teo I., Greenough T., et al. Persistence of episomal HIV-1 infection intermediates in patients on highly active anti-retroviral therapy. Nat. Med. 6:2000;76-81.
34. Staprans S.I., Dailey P.J., Rosenthal A., Horton C., Grant R.M., Lerche N., Feinberg M.B. Simian immunodeficiency virus disease course is predicted by the extent of virus replication during primary infection. J. Virol. 73:1999;4829-4839.
35. Spina C.A., Kwoh T.J., Chowers M.Y., Guatelli J.C., Richman D.D. The importance of nef in the induction of human immunodeficiency virus type 1 replication from primary quiescent CD4 lymphocytes. J. 179:1994;115-123.
36. Swingler S., Mann A., Jacque J., Brichacek B., Sasseville V.G., Williams K., Lackner A.A., Janoff E.N., Wang R., Fisher D., Stevenson M. HIV-1 Nef mediates lymphocyte chemotaxis and activation by infected macrophages. Nat. Med. 5:1999;997-1003.
37. Teo I., Veryard C., Barnes H., An S.F., Jones M., Lantos P.L., Luthert P., Shaunak S. Circular forms of unintegrated human immunodeficiency virus type 1 DNA and high levels of viral protein expression association with dementia and multinucleated giant cells in the brains of patients with AIDS. J. Virol. 71:1997;2928-2933.
38. Watson A., Ranchalis J., Travis B., McClure J., Sutton W., Johnson P.R., Hu S.-H., Haigwood N.L. Plasma viraemia in macaques infected with simian immunodeficiency virus Plasma viral load early in infection predicts survival. J. Virol. 71:1997;284-290.
39. Xu X.N., Laffert B., Screaton G.R., Kraft M., Wolf D., Kolanus W., Mongkolsapay J., McMichael A.J., Baur A.S. Induction of Fas ligand expression by HIV involves the interaction of Nef with the T cell receptor zeta chain. J. Exp. Med. 189:1999;1489-1496.
40. Xu X.N., Screaton G.R., Gotch F.M., Dong T., Tan R., Almond N., Walker B., Stebbings R., Kent K., Nagata S., Stott J.E., McMichael A.J. Evasion of cytotoxic T lymphocyte (CTL) responses by nef-dependent induction of Fas ligand (CD95L) expression on simian immunodeficiency virus-infected cells. J. Exp. Med. 186:1997;7-16.
41. Zhou J., Aiken C. Nef enhances human immunodeficiency virus type 1 infectivity resulting from intervirion fusion evidence supporting a role for nef at the virion envelope. J. Virol. 75:2001;5851-5859.